Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

61. Integrated care for atrial fibrillation

Integrated care for atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

62. Sex-specific outcomes of radiofrequency versus cryoballoon catheter ablation for atrial fibrillation: a systematic review

Sex-specific outcomes of radiofrequency versus cryoballoon catheter ablation for atrial fibrillation: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

63. Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: a systematic review and patient-level meta-analysis of randomized controlled trials and cohort studies

Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: a systematic review and patient-level meta-analysis of randomized controlled trials and cohort studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

64. Safety and efficacy of anticoagulant and antiplatelet combination treatment strategies in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: a network meta-analysis of randomized clinical trials

Safety and efficacy of anticoagulant and antiplatelet combination treatment strategies in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: a network meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

65. Dual versus triple therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: a pairwise meta-analysis of randomized clinical trials

Dual versus triple therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: a pairwise meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

66. Effects of early recurrence of atrial fibrillation on late atrial fibrillation recurrence: a systematic review and meta-analysis

Effects of early recurrence of atrial fibrillation on late atrial fibrillation recurrence: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

67. Diagnostic accuracy of smartphone cameras to detect Atrial Fibrillation or Atrial Flutter: a systematic review and meta-analysis

Diagnostic accuracy of smartphone cameras to detect Atrial Fibrillation or Atrial Flutter: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

68. Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: a systematic review and meta-analysis

Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

69. Antithrombotic strategies in adult patients undergoing atrial fibrillation ablation: systematic review and meta-analysis of randomized controlled trials

Antithrombotic strategies in adult patients undergoing atrial fibrillation ablation: systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

70. A meta-analysis of continuous positive airway pressure treating obstructive sleep apnea with atrial fibrillation

A meta-analysis of continuous positive airway pressure treating obstructive sleep apnea with atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

71. Factors influencing oral anticoagulant prescribing decisions for patients with atrial fibrillation: a systematic review of qualitative and quantitative evidence

Factors influencing oral anticoagulant prescribing decisions for patients with atrial fibrillation: a systematic review of qualitative and quantitative evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

72. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis [Cochrane protocol]

External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

73. Anticoagulant agents for preventing thromboembolic events in patients with atrial fibrillation and chronic kidney disease 3-5D stage: a systematic review

Anticoagulant agents for preventing thromboembolic events in patients with atrial fibrillation and chronic kidney disease 3-5D stage: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

74. Dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

75. Associations of cardiac biomarkers and ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis

Associations of cardiac biomarkers and ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

76. The role of contact force and indices of transmural lesion formation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis

The role of contact force and indices of transmural lesion formation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

77. Single oral dose anti-arrhythmics for conversion of atrial fibrillation episodes (SODA-CAFE)

Single oral dose anti-arrhythmics for conversion of atrial fibrillation episodes (SODA-CAFE) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

78. Colchicine for prevention of post-lung resection and cardiac procedure atrial fibrillation: a meta-analysis of randomized controlled trials

Colchicine for prevention of post-lung resection and cardiac procedure atrial fibrillation: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

79. Clinical service organisation for adults with atrial fibrillation [Cochrane protocol]

Clinical service organisation for adults with atrial fibrillation [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

80. Impacts of physical exercise on atrial fibrillation

Impacts of physical exercise on atrial fibrillation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO